PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91022P00328ANNUAL institution WIDE subscription to the — Cancer Letter Inc., the

Cancer Letter Inc., the holds $150K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Mar 20, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nih Nci

Awarding office

Cancer Letter Inc., the

Recipient

Mar 20, 2026

PoP end

$150K

Obligated

$300K

Potential

519130

NAICS

R499

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Cancer Letter Inc., the — $90

Contract facts

NONE

Contract number75N91022P00328

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentCancer Letter Inc., the

CAGE35BP3

UEIH3SMDHHKCTT3

NAICS519130

No full NAICS 519130 intel page yet. Browse NAICS intelligence

PSCR499

Place of performanceWASHINGTON DC

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startMar 21, 2022

PoP end (current)Mar 20, 2026

PoP end (w/ options)Mar 20, 2027

Obligated$150K

Current value$200K

Potential value$300K

ANNUAL INSTITUTION WIDE SUBSCRIPTION TO THE CANCER LETTER PUBLICATION is a federal NONE award for Nih Nci held by Cancer Letter Inc., the. Estimated value $300K ($150K obligated). Current period of performance ends Mar 20, 2026 (potential Mar 20, 2027). Last award drew 1 bidder. Place of performance: WASHINGTON DC.

ANNUAL INSTITUTION WIDE SUBSCRIPTION TO THE CANCER LETTER PUBLICATION

Recompete timing

Public

● Past PoP end (173 days ago)

Current PoP ended Mar 20, 2026 (173 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Cancer Letter Inc., the — $150K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$150K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91022P00328?

75N91022P00328 (ANNUAL institution WIDE subscription to the) is a Nih Nci award with a potential value of $300K, currently held by Cancer Letter Inc., the. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91022P00328?

Nih Nci awarded 75N91022P00328 to Cancer Letter Inc., the (potential $300K).

Who is the incumbent on 75N91022P00328?

Cancer Letter Inc., the is the incumbent with $150K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Mar 20, 2026.

When does Cancer Letter Inc., the’s 75N91022P00328 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 20, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91022P00328 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Mar 24, 2025